Cowen Healthcare Investments, an investor in healthcare companies across the biopharma, diagnostics and digital health sectors, has closed its Cowen Healthcare Investments IV with total committed capital of $555.6 million.

CHI IV will invest primarily in mid- to late-stage life sciences opportunities. Led by Kevin Raidy, Tim Anderson and Robert Sine, Cowen Healthcare Investments aims to capitalize on value-creation opportunities in both private and public markets. Since its founding in 2012, the CHI team has invested in more than 60 healthcare companies and manages more than $1 billion.

“We will continue to seek life sciences investment opportunities with exciting potential to advance the healthcare landscape,” comments Raidy.